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NIGMS National Centers for Systems Biology
The National Institute of General Medical Sciences
(NIGMS) currently supports the analysis of complex
biological systems through investigator-initiated
research project grants. The resources needed to con-
duct the multifaceted, multidisciplinary projects that
may be required to achieve significant advances in
these complex areas may be beyond the scope of the
typical R01 or P01 grant. Therefore, this request for
applications (RFA) presents an opportunity for appli-
cants to assemble large teams of investigators from
diverse disciplines that may not be possible with other
funding mechanisms.
The biomedical sciences have undergone a funda-
mental shift in the conceptual and technical
approaches that can be applied to certain problems of
profound importance. These problems center on
understanding the behavior of biological systems whose
function is the product of spatial and temporal order-
ing of myriad interacting components. Modeling
approaches are being used to understand the orderly
development of biological pattern in organisms such as
Drosophila and Caenorhabditis elegans, and at the clini-
cal level, new approaches are being explored to under-
stand the integrated activity of tissues and organs. 
Part of the impetus for systems-scale approaches
rests on advances in acquiring data of the necessary
quality and quantity to permit computational model-
ing. Among the most striking examples are the avail-
ability of complete DNA sequences for hundreds of
organisms, including humans, and the availability of
high-throughput instrumentation for analyses of gene
function such as gene expression microarrays and pro-
teomics technologies. These advances have made it fea-
sible to generate a truly comprehensive parts list for any
organism and to track changes over time. Ultimately, it
should be possible to enumerate all the informational
units of the genomes (protein coding genes, non–pro-
tein coding genes, regulatory regions), their processed
forms, and their dynamic presence in cells. 
Rapid advances in large-scale data collection and
analysis have given scientists a global yet detailed view
of cellular processes, instead of focusing on individual
molecules or a small number of interacting molecules.
Unprecedented opportunities have emerged that may
open the door to uncover hidden rules governing the
ensemble of biomolecules working concertedly to per-
form certain functions in the cell. In the meantime,
substantial challenges in information integration, inter-
pretation, and representation have arisen. In order to
move beyond the phase of cataloguing the parts list
and truly transform data into knowledge, and knowl-
edge into principles, iterative cycles of data collection
and model generation and validation will be necessary. 
A higher-order problem presents itself in under-
standing how the genome-encoded components and
the other molecules (metabolites, ions, water, etc.) are
constituted in networks of interacting molecules with
particular distributions in time and space. Advances in
imaging techniques and analytic methods are begin-
ning to yield copious quantitative and spatial data on
speciﬁc molecules in biological systems. Knowledge of
the network and changes in its components over time,
and the local rules by which the individual components
distribute material and information, will substantially
advance our knowledge.
At the organism level, phenotype must take into
account the relationships and interactions of biological
and environmental variables. Basic biological sys-
tems—including gene sequences, structures, and path-
ways that direct metabolism and development—vary
within individuals, among individuals, among popula-
tions, and among species. Advances in complex sys-
tems-level understanding must ultimately include
models that account for these variations. 
Medical, biotechnological, and other uses of bio-
logical information increasingly depend on our ability
to understand the principles and dynamics that explain
the behavior of the system as a whole. Whether the
goal is to understand the consequences of disease or
injury, identify particular molecular targets for drug
interventions, or modify the metabolism of microor-
ganisms to produce medicines, the challenge is pre-
dictability. Predicting how the system of interest will
respond to an intervention is a computational problem.
For biological systems, this challenge is daunting. 
Parallel to scientiﬁc challenges are organizational
and educational challenges. At the institutional level,
building cohesive multidisciplinary research teams by
integrating expertise across traditional disciplinary
boundaries is not a simple undertaking. Beyond insti-
tutions, excessive overlap and redundancy in project
selection and tool development exists in the research
communities that could be reduced by promoting
communications, collaborations, and technology and
data sharing. The emergence of new science demands
an adequate workforce of new scientists. Training for
the future leaders of systems biology research who are
knowledgeable and skilled in both experimental and
computational subjects is timely. Good mechanisms
and plans to address these challenges are significant
tasks of the centers.
High priority will be given to projects that inte-
grate multi-investigator, multidisciplinary approaches
with a high degree of interplay between computational
and experimental approaches. Innovation is critical for
both research project design and infrastructure design
with a mission of serving communities beyond the par-
ticipating investigators, institutions, and collaborators.
A variety of organizational models are possible; it is not
the intent of this RFA to prescribe any particular one.
The NIGMS awarded two centers under this pro-
gram in 2002 (http://www.nigms.nih.gov/news/releases/
complex_centers.html), two centers in 2003 (http://
www.nigms.nih.gov/news/releases/complex_
centers-2003.html), and one center in 2004 (http://www.
nigms.nih.gov/news/releases/quantitative_bio_center.
html). Potential applicants should become familiar
with the research focuses of the existing centers.
Research conducted by the future centers should com-
plement and enhance projects already funded.
Some groups interested in the subject of this RFA
might ﬁnd the P01 mechanism more suited to the scale
of their efforts; they should consult the prior
announcement at http://grants.nih.gov/grants/guide/
pa-ﬁles/PA-98-077.html.
The NIGMS intends to support systems biology
research for the areas that are central to its mission of
supporting basic biomedical research, and that focus on
developing new computational approaches to biomed-
ical complexity. Research areas that historically have
been computationally based (e.g., molecular structure
and modeling) are excluded as a focus of this center
program. Research focusing on disease processes and
their specific organ systems is not eligible. NIGMS
mission areas include, but are not limited to, the fol-
lowing: 1) signaling networks and the regulatory
dynamics of cellular processes such as cell cycle control,
transient complex formation, organelle biogenesis, and
intercellular communications; 2) supramolecular
machines, such as the replisome, spliceosome, and mol-
ecular motor assemblies in cell division and motility; 3)
pattern formation and developmental processes in
model systems (e.g., Drosophila, C. elegans, etc.); 4)
metabolic networks and the control of the ﬂux of sub-
strates, intermediates, and products in cell physiology;
5) organ system networks involved in multiorgan fail-
ure in shock, trauma, and burn injury; and 6) genetic
architecture of biological complexity related to inher-
ited variation and environmental ﬂuctuations.
The NIGMS National Centers for Systems
Biology will be expected to provide national leadership
in systems biology research and training. To do so,
they will be expected to support training and outreach
activities that will ensure the ﬂow of information and
expertise both into and out of the centers. Centers
should have plans to bring the most advanced tech-
nologies developed at other laboratories to the centers
and to disseminate expertise and knowledge to a wider
community through collaborations, visiting investiga-
torships, fellowships, center websites, workshops, sym-
posia, summer courses/internships, and/or other
means. To maximize the impact, centers should con-
duct training at multiple levels appropriate to their
institutions. Incorporation of developmental research
projects led by junior and new investigators into the
center research and development plans is strongly
encouraged. Over a period of time, centers should
evolve into integrated research, training, and knowl-
edge exchange headquarters of scientiﬁc communities
that will be the engines for coordinated scientiﬁc dis-
coveries. The centers should also have plans for out-
reach to undergraduate institutions, including
minority-serving institutions. Information on relevant
minority-serving institutions may be obtained by con-
sultation with staff of the NIGMS Division of
Minority Opportunities in Research (http://www.
nigms.nih.gov/about_nigms/more.html).
In addition to research and training contributions,
successful centers will provide their home institutions
with the means to implement organizational and pro-
fessional changes that will make systems biology
research an attractive career option for both established
and entry-level investigators.
This funding opportunity will use the NIH P50
Research Center Grant award mechanism. As an
applicant, you will be solely responsible for planning,
directing, and executing the proposed project. This
RFA is a one-time solicitation and may be rean-
nounced in the future. The earliest expected award
date is in December 2005. Applications that were
submitted in response to previous RFAs of this pro-
gram but unfunded may be revised and resubmitted
for this RFA.
The NIGMS intends to commit up to $7 million
in ﬁscal year 2006 to fund one to three new P50 center
grants in response to this RFA. An applicant may
request a project period of up to ﬁve years and a budget
for direct costs of up to $2 million per year, exclusive
of subproject fiscal and administrative costs (see
http://grants.nih.gov/grants/guide/notice-files/
NOT-OD-04-040.html).
The PHS 398 application instructions are avail-
able at http://grants.nih.gov/grants/funding/
phs398/phs398.html in an interactive format. For fur-
ther assistance, contact GrantsInfo by calling 301-435-
0714 or e-mailing GrantsInfo@nih.gov.
Applications must be prepared using the PHS 398
application instructions and forms (rev. 5/2001).
Applications must have a Dun & Bradstreet (D&B)
Data Universal Numbering System number as the uni-
versal identifier when applying for federal grants or
cooperative agreements. This number can be obtained
by calling 1-866-705-5711 or online at http://www.
dnb.com/us/. The D&B number should be entered on
line 11 of the face page of the PHS 398 form. 
Letters of intent must be received by 25 January
2005, with 25 February 2005 the deadline for applica-
tions. The complete version of this announcement is
available online at http://grants.nih.gov/grants/
guide/rfa-ﬁles/RFA-GM-05-010.html#PartI. 
Contact: James J. Anderson, Center for Bioinfor-
matics and Computational Biology, NIGMS, 45
Center Dr, Rm 2As.25A, MSC 6200, Bethesda, MD
20892-6200 USA, 301-594-0943, fax: 301-480-2228,
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Center for Bioinformatics and Computational Biology,
NIGMS, 45 Center Dr, Rm 2As.19F, MSC 6200,
Bethesda, MD 20892-6200 USA, 301-594-0682, fax:
301-480-2004, e-mail: lij@nigms.nih.gov. Reference:
RFA No. RFA-GM-03-009
Environmental and Human Health Effects of
Manufactured Nanomaterials
The purpose of this collaborative research program is
to strengthen support by the Environmental Protection
Agency (EPA), the National Science Foundation
(NSF), and the National Institute for Occupational
Safety and Health (NIOSH) of research on the poten-
tial implications of nanotechnology and manufactured
nanomaterials on human health and the environment.
Research areas of interest include the toxicology, fate,
transport/transformation, and bioavailability of nano-
materials, as well as human exposures to these materi-
als. Proposals should address one of these topics.
The EPA supports research to meet its mission of
protecting the environment and human health.
Information used in risk assessment, which comprises
hazard identiﬁcation and exposure assessment, is cen-
tral to the EPA’s methods to meet its mission. As such,
the EPA is interested in funding research on the possi-
ble risks and exposure routes of newly produced chemi-
cals and materials at the nanoscale.
At the NSF, proposals should assist and enable the
engineering and scientiﬁc communities to advance the
frontiers of research, innovation, and education. The
research should focus on emerging and potentially
transformative research ideas, application of new exper-
tise, or new approaches to established research topics.
NIOSH supports research to identify and investi-
gate the relationships between hazardous working con-
ditions and associated occupational diseases and
injuries; to develop more sensitive means of evaluating
hazards at work sites, as well as methods for measuring
early markers of adverse health effects and injuries; to
develop new protective equipment, engineering control
technology, and work practices to reduce the risk of
occupational hazards; and to evaluate the technical fea-
sibility or application of a new or improved occupa-
tional safety and health procedure, method, technique,
or system.
Nanotechnology has been deﬁned by the intera-
gency Subcommittee on Nanoscale Science, Engi-
neering, and Technology of the federal Office of
Science and Technology Policy as research and tech-
nology development at the atomic, molecular, or
macromolecular levels, in the length scale of approxi-
mately 1- to 100-nanometer (nm) range, to provide a
fundamental understanding of phenomena and mate-
rials at the nanoscale, and to create and use structures,
devices, and systems that have novel properties and
functions because of their small and/or intermediate
size. The novel and differentiating properties and
functions are developed at a critical length scale of
matter typically under 100 nm. Nanotechnology
research and development includes manipulation
under control of the nanoscale structures and their
integration into larger material components, systems,
and architectures. Within these larger-scale assem-
blies, the control and construction of their structures
and components remains at the nanometer scale. In
some particular cases, the critical length scale for
novel properties and phenomena may be under 1 nm
(e.g., manipulation of atoms ~0.1 nm) or larger than
100 nm (e.g., nanoparticle-reinforced polymers have
the unique feature at ~200–300 nm as a function of
the local bridges or bonds between the nanoparticles
and the polymer). See http://www.nano.gov/ for
more information.
Many industries are currently involved in nano-
technology-related activities. Among these activities is
the manufacture of nanoscale materials that are used in
a wide range of products, such as sunscreens, compos-
ites, medical devices, and chemical catalysts. According
to data collected by the National Nanotechnology
Initiative, the quantity of manufactured nanoscale
materials is expected to grow signiﬁcantly in the next
five years. Business Communications Company has
projected a $10 billion global demand for nanoscale
materials, tools, and devices in 2010. This large
increase in demand and production could lead to envi-
ronmental exposures of humans and other organisms
to nanoscale materials.
There is a serious lack of information about the
human health and environmental implications of man-
ufactured nanomaterials, e.g., nanoparticles, nan-
otubes, nanowires, fullerene derivatives, and other
nanoscale materials. Environmental and other safety
concerns about nanotechnology have been raised. As
part of the missions of the EPA and NIOSH to protect
human health and the environment, this solicitation
requests research proposals that address potential health
and environmental concerns of nanomaterials using the
best science available, in keeping with the missions of
the NSF and the other agencies.
Potentially harmful effects of nanotechnology
might arise as a result of the nature of the nanoparti-
cles themselves, the characteristics of the products
made from them, or aspects of the manufacturing
process involved. The large surface area, crystalline
structure, and reactivity of some nanoparticles may
facilitate transport in the environment or lead to harm
because of their interactions with cellular material.
The size of nanomaterials could facilitate and exacer-
bate any harmful effects caused by the composition of
the material.
Some research has been done on inhalational and
dermal exposure to nanoparticles. However, the cur-
rent research on ultraﬁne particles may not be applica-
ble to manufactured nanoparticles because the ultraﬁne
materials studied are neither a consistent size nor pure
in chemical or structural composition. Exposure may
occur via the dermal and ingestion routes, as well as the
inhalational route. It is unknown whether nanomateri-
als bioaccumulate and thereby pose human health and
environmental risks.
Little is known about the fate, transport, and
transformation of nanomaterials after they enter the
environment. As the production of manufactured
nanomaterials increases and as products containing
manufactured nanomaterials are disposed of, these
materials could have harmful effects as they move
through the environment.
The RFA sponsors are particularly interested in
supporting research related to manufactured nano-
materials in the following areas: 
1) Toxicology of manufactured nanomaterials. What
is the toxicity/potential toxicity of manufactured nano-
materials? Can similar nanomaterials be grouped with
respect to their bioactivity? What are the health effects
associated with nanomaterial mixed exposures or mul-
tiple exposure routes? What are the dose–response
characteristics of nanomaterials? What are appropriate
testing procedures, models, and biomarkers to evaluate
the potential toxicological effects of nanomaterials in
humans and/or other species in natural ecosystems?
What extrapolation models are needed to evaluate or
predict toxicity? What is the mode of action and mech-
anism of toxicity? What effects may occur in exposed
human and wildlife populations? Are some subpopula-
tions more sensitive to nanomaterials? Do nanoparti-
cles impact ecological (animal/plant) receptors?
2) Environmental and biological fate, transport, and
transformation of manufactured nanomaterials. By what
means do/can manufactured nanomaterials enter the
environment? What are the modes of dispersion for
nanomaterials in the environment? Do manufactured
nanoparticles undergo transformation in the environ-
ment? Do manufactured nanoparticles bioaccumulate
through the food chain?
3) Exposure and bioavailability of manufactured
nanomaterials. How and to what degree are humans
exposed to nanomaterials in the environment and
workplace? What effects may occur in exposed human
populations and occupations? Are some subpopula-
tions more vulnerable to nanomaterial exposure? What
are the exposure pathways for humans? What are the
effects of nanomaterials and mixtures on engineering
controls and personal protective equipment? What
releases might occur from the manufacturing processes
of nanomaterials? At what stage in the product life
cycle might exposure occur? How will changes from
current processes to nanotechnology processes affect
material ﬂows of hazardous substances? What are the
life cycle impacts from the manufacturing processes for
nanomaterials?
Because the manufacturing of nanomaterials is not
widespread and nomenclature is not standard,
researchers must indicate in their proposals which
nanomaterials they will use and where they will obtain
them, including any needed collaboration with a mate-
rials manufacturing corporation or research lab that is
synthesizing a commercially viable material. Thus, in
the proposal, information on the source, potential use,
composition, and present or future availability of the
material being studied must be included. Researchers
are encouraged to explore the appropriateness and
availability of special nanotechnology user facilities at
the Department of Energy; see http://www.nano.gov/
html/centers/DOEcenters.html. The National
Institute of Standards and Technology also offers user
facilities; see http://www.nano.gov/html/centers/
NISTcenters.html for information.
It is anticipated that a total of approximately
$7 million will be awarded, depending on the avail-
ability of funds. The EPA intends to commit up to
$5 million in fiscal year 2005, NIOSH intends to
commit up to $1 million, and the NSF intends to
commit up to $1 million. Depending on the proposal
types, 16–20 awards may be given.
For a standard (e.g., R01 type) grant, an applicant
may request a project period of up to three years and a
budget for total costs (direct and indirect) not to
exceed $400,000 total for a three-year period. For an
exploratory (e.g., R21, SGER type) grant mechanism,
an applicant may request a project period of up to two
years and a budget for total costs (direct and indirect)
not to exceed $200,000 total for a two-year period.
Although the ﬁnancial plans of the EPA, NIOSH, and
the NSF provide support for this program, awards pur-
suant to this RFA are contingent upon the availability
of funds and the receipt of a sufﬁcient number of meri-
torious applications. Proposals with budgets exceeding
the total award limits will not be considered. This RFA
will use EPA, NIOSH, and NSF award mechanisms. 
Applications must be received by 5 January 2005.
The complete version of this announcement is
available online at http://es.epa.gov/ncer/rfa/2004/
2004_manufactured_nano.html. 
Contact: Barbara Karn, EPA, 202-343-9704, e-
mail: karn.barbara@epa.gov; Nora Savage, EPA, 202-
343-9858, e-mail: savage.nora@epa.gov; Cynthia J.
Ekstein, NSF, 703-292-7941, e-mail: cekstein@
nsf.gov; Adele M. Childress, Office of Extramural
Programs, NIOSH, CDC, 1600 Clifton Rd NE,
Executive Park, Bldg 24, Rm 1427, MS E-74,
Atlanta, GA 30333 USA, 404-498-2509, fax: 404-
498-2571, e-mail: ahc0@cdc.gov. Reference: STAR-
2005-B1
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